In Brief: FDA budget
This article was originally published in The Gray Sheet
Executive Summary
FDA budget: Fiscal year 1999 budget proposal for FDA and other federal agencies slated for release Feb. 2. Like last year's proposal, the FY 1999 budget is expected to call for device user fees for deficit reduction. Hearings on FDA's budget are slated for Feb. 12 and March 31 by House and Senate Appropriations subcommittees, respectively. FDA is in ongoing discussions with the subcommittees over its fiscal 1998 operating plan. The agency recently delivered a revised plan after the first one was rejected as too general ("The Gray Sheet" Jan. 19, p. 9)...
You may also be interested in...
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.